Dung My Phan, MD
Family Practice · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 32
- 9 carriers
- Office
- 1
Offices
1 location
Plans that list them
32 plans · 9 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Phan’s office at (408) 274-3881 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
32 of 32 plans
| Alignment Health Advantage PPO (PPO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Prime (HMO-POS) | Anthem Blue Cross Partnership Plan | Listed | Oct 3, 2026 |
| Astiva Health C-SNP WOW - NorCal (HMO C-SNP) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Premier Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Savings Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Blue Shield Inspire (HMO) | Blue Shield of California | Listed | Aug 26, 2026 |
| Central Health Classic Care Plan III (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Dual Access Plan (HMO D-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Embrace Choice Plan (HMO C-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Valor Care Plan (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| AARP Medicare Advantage from UHC CA-10 (HMO-POS) | UnitedHealthcare | Listed, may be out of date | Jun 10, 2026 |
California Medical Board record
Licence A42236 · Current
Licensed to practise in California · since 1985 · expires 2027-09-30 · University of Saigon Faculty of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Original Medicare doctor bills
$63,470
Medicare paid this office $63,470 for 172 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Telephone medical discussion with physician, 21-30 minutes | 103 | $18,828 | $114 |
| Short return visit (20+ min) | 139 | $18,811 | $73 |
| Return visit (30+ min) | 91 | $12,035 | $86 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 47 | $7,381 | $157 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 125 | $3,152 | $15 |
See all 6 services
| Telephone medical discussion with physician, 21-30 minutes | 103 | $18,828 | $114 |
| Short return visit (20+ min) | 139 | $18,811 | $73 |
| Return visit (30+ min) | 91 | $12,035 | $86 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 47 | $7,381 | $157 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 125 | $3,152 | $15 |
| Telephone medical discussion with physician, 11-20 minutes | 51 | $2,479 | $42 |
Who their Medicare patients are
172 Original Medicare patients in 2024. Average age 72 · Under 65 6% · 85 and older 10% · Women 80% · Also on Medicaid 92% · Health risk score 0.95. At or below the middle of the specialty; the typical family practice clinician is at 1.13.
Conditions among them: High blood pressure 75% · Diabetes 65% · Chronic kidney disease 25% · Coronary heart disease 9% · Depression 8% · Dementia 8% · Cancer 6%.
The office billed $132,940, Medicare allowed $89,622 and paid $63,470; for 893 services of 9 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 172 | 893 | 72 | 0.95 | $132,940 | $63,470 |
| 2023 | 175 | 738 | 71 | 0.82 | $116,910 | $39,322 |
| 2022 | 182 | 1,046 | 72 | 0.88 | $131,935 | $52,604 |
| 2021 | 168 | 797 | 72 | 0.77 | $87,730 | $42,665 |
| 2020 | 82 | 287 | 72 | 0.78 | $31,350 | $11,665 |
| 2019 | 236 | 981 | 70 | 0.91 | $123,735 | $83,882 |
| 2018 | 227 | 1,041 | 70 | 0.93 | $123,050 | $81,335 |
| 2017 | 199 | 798 | 70 | 0.93 | $92,230 | $60,481 |
| 2016 | 203 | 745 | 70 | 0.92 | $90,520 | $59,241 |
| 2015 | 229 | 928 | 71 | 0.91 | $105,754 | $66,290 |
| 2014 | 246 | 1,099 | 71 | 0.90 | $120,955 | $75,592 |
| 2013 | 289 | 1,465 | 71 | 0.95 | $147,530 | $92,850 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 5 services
| Return visit (30+ min) | 114 | $13,144 | $68 |
| Short return visit (20+ min) | 119 | $9,769 | $48 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 55 | $8,575 | $156 |
| Telephone medical discussion with physician, 5-10 minutes | 131 | $5,832 | $23 |
| Telephone medical discussion with physician, 11-20 minutes | 25 | $1,609 | $60 |
2022: 4 services
| Return visit (30+ min) | 125 | $16,203 | $69 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 81 | $12,187 | $150 |
| Short return visit (20+ min) | 135 | $11,596 | $43 |
| Telephone medical discussion with physician, 5-10 minutes | 166 | $11,581 | $26 |
2021: 4 services
| Return visit (30+ min) | 109 | $15,742 | $83 |
| Telephone medical discussion with physician, 5-10 minutes | 152 | $10,324 | $29 |
| Short return visit (20+ min) | 114 | $10,067 | $49 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 39 | $5,850 | $150 |
2020: 4 services
| Return visit (30+ min) | 52 | $4,559 | $65 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 21 | $2,982 | $142 |
| Short return visit (20+ min) | 54 | $2,816 | $37 |
| Qualified nonphysician healthcare professional online assessment and management service, for an established patient, for up to seven days, cumulative time during the 7 days; 5-10 minutes | 69 | $1,067 | $9 |
2019: 6 services
| Return visit (30+ min) | 169 | $39,529 | $89 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 139 | $19,535 | $141 |
| Short return visit (20+ min) | 163 | $19,379 | $58 |
| Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | 16 | $2,377 | $149 |
| Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | 22 | $1,199 | $54 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 21 | $989 | $47 |
2018: 9 services
| Return visit (30+ min) | 169 | $36,617 | $86 |
| Short return visit (20+ min) | 158 | $16,194 | $54 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 118 | $16,066 | $136 |
| Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | 23 | $3,381 | $147 |
| Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | 12 | $2,117 | $176 |
| Influenza vaccine split virus, preservative free | 44 | $1,985 | $45 |
| Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | 32 | $1,716 | $54 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 33 | $1,459 | $44 |
| Administration of influenza virus vaccine | 43 | $1,054 | $25 |
2017: 8 services
| Return visit (30+ min) | 141 | $26,667 | $86 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 96 | $12,772 | $133 |
| Short return visit (20+ min) | 124 | $11,680 | $55 |
| Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | 20 | $2,881 | $144 |
| Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | 33 | $1,761 | $53 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 33 | $1,456 | $44 |
| Influenza vaccine split virus, preservative free | 36 | $931 | $25 |
| Administration of influenza virus vaccine | 36 | $931 | $25 |
2016: 10 services
| Return visit (30+ min) | 123 | $22,870 | $91 |
| Short return visit (20+ min) | 131 | $14,159 | $59 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 74 | $9,983 | $135 |
| Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | 53 | $2,875 | $54 |
| Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | 18 | $2,646 | $147 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 51 | $2,265 | $44 |
| Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | 11 | $1,940 | $176 |
| New patient visit (30+ min) | 13 | $987 | $76 |
| Influenza vaccine split virus, preservative free | 13 | $319 | $25 |
| Administration of influenza virus vaccine | 12 | $294 | $25 |
2015: 9 services
| Short return visit (20+ min) | 169 | $23,631 | $61 |
| Return visit (30+ min) | 122 | $19,261 | $88 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 62 | $8,452 | $136 |
| Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | 55 | $3,046 | $55 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 56 | $2,540 | $45 |
| Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | 14 | $2,068 | $148 |
| New patient visit (30+ min) | 15 | $1,502 | $100 |
| Administration of influenza virus vaccine | 39 | $1,029 | $25 |
| Influenza vaccine split virus, preservative free | 37 | $980 | $25 |
2014: 8 services
| Short return visit (20+ min) | 182 | $32,184 | $60 |
| Return visit (30+ min) | 107 | $18,835 | $91 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 79 | $10,588 | $134 |
| Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | 75 | $4,055 | $54 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 68 | $3,021 | $44 |
| Administration of influenza virus vaccine | 44 | $1,103 | $25 |
| Influenza vaccine split virus, preservative free | 35 | $882 | $25 |
| Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluzone) | 12 | $142 | $12 |
2013: 10 services
| Short return visit (20+ min) | 220 | $41,026 | $58 |
| Return visit (30+ min) | 129 | $19,765 | $92 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 77 | $10,229 | $133 |
| Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | 95 | $5,357 | $56 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 110 | $4,994 | $45 |
| New patient visit (30+ min) | 39 | $3,707 | $95 |
| Influenza virus vaccine, split virus, for intramuscular use (agriflu) | 75 | $2,200 | $29 |
| Administration of influenza virus vaccine | 75 | $1,899 | $25 |
| Administration of pneumococcal vaccine | 15 | $477 | $32 |
| Pneumococcal vaccine, 23-valent | 13 | $448 | $34 |
Medicaid work
$3,366 in 2024
Medicaid paid $3,366 for 2,484 billed services this clinician did in 2024, up to 113 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Return visit (30+ min) | 346 | $2,332 |
| Short return visit (20+ min) | 977 | $915 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 12 | $119 |
| Most recent systolic blood pressure less than 130 mm Hg (DM) (HTN, CKD, CAD) | 230 | $0 |
| Most recent systolic blood pressure 130-139 mm Hg (DM) (HTN, CKD, CAD) | 41 | $0 |
| Most recent diastolic blood pressure less than 80 mm Hg (HTN, CKD, CAD) (DM) | 156 | $0 |
| Most recent diastolic blood pressure 80-89 mm Hg (HTN, CKD, CAD) (DM) | 60 | $0 |
| Most recent diastolic blood pressure greater than or equal to 90 mm Hg (HTN, CKD, CAD) (DM) | 49 | $0 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; 40-64 years | 81 | $0 |
| Smoking and tobacco use cessation counseling visit; intermediate, greater than 3 minutes up to 10 minutes | 84 | $0 |
| Alcohol and/or substance (other than tobacco) abuse structured screening (eg, AUDIT, DAST), and brief intervention (SBI) services; 15 to 30 minutes | 47 | $0 |
| Screening for depression is documented as being positive and a follow-up plan is documented | 291 | $0 |
| 2024 | 2,484 | 13 | 113 | $3,366 |
| 2023 | 6,666 | 21 | 119 | $7,041 |
| 2022 | 5,916 | 17 | 110 | $2,242 |
| 2021 | 6,812 | 25 | 285 | $1,543 |
| 2020 | 3,818 | 12 | 263 | $5,437 |
| 2019 | 4,469 | 17 | 143 | $4,583 |
| 2018 | 4,415 | 16 | 232 | $9,004 |
See the largest Medicaid services in earlier years
2023
| Return visit (30+ min) | 1,080 | $4,764 |
| Short return visit (20+ min) | 1,352 | $2,081 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 14 | $139 |
| Telephone evaluation and management service by a physician or other qualified health care professional who may report evaluation and management services provided to an established patient, parent, or guardian not originating from a related E/M service provided within the previous 7 days nor leading to an E/M service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion | 92 | $57 |
| Most recent systolic blood pressure less than 130 mm Hg (DM) (HTN, CKD, CAD) | 1,022 | $0 |
| Most recent systolic blood pressure 130-139 mm Hg (DM) (HTN, CKD, CAD) | 239 | $0 |
| Most recent systolic blood pressure greater than or equal to 140 mm Hg (HTN, CKD, CAD) (DM) | 25 | $0 |
| Most recent diastolic blood pressure less than 80 mm Hg (HTN, CKD, CAD) (DM) | 1,082 | $0 |
| Most recent diastolic blood pressure 80-89 mm Hg (HTN, CKD, CAD) (DM) | 256 | $0 |
| Most recent diastolic blood pressure greater than or equal to 90 mm Hg (HTN, CKD, CAD) (DM) | 47 | $0 |
| Medical nutrition therapy; re-assessment and intervention, individual, face-to-face with the patient, each 15 minutes | 50 | $0 |
| Short return visit | 15 | $0 |
2022
| Return visit (30+ min) | 890 | $1,025 |
| Short return visit (20+ min) | 1,393 | $893 |
| Influenza virus vaccine, trivalent (IIV3), split virus, 0.5 mL dosage, for intramuscular use | 33 | $297 |
| Telephone evaluation and management service by a physician or other qualified health care professional who may report evaluation and management services provided to an established patient, parent, or guardian not originating from a related E/M service provided within the previous 7 days nor leading to an E/M service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion | 134 | $26 |
| Most recent systolic blood pressure less than 130 mm Hg (DM) (HTN, CKD, CAD) | 498 | $0 |
| Most recent systolic blood pressure 130-139 mm Hg (DM) (HTN, CKD, CAD) | 129 | $0 |
| Most recent systolic blood pressure greater than or equal to 140 mm Hg (HTN, CKD, CAD) (DM) | 26 | $0 |
| Most recent diastolic blood pressure less than 80 mm Hg (HTN, CKD, CAD) (DM) | 558 | $0 |
| Most recent diastolic blood pressure 80-89 mm Hg (HTN, CKD, CAD) (DM) | 105 | $0 |
| Short return visit | 341 | $0 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; 18-39 years | 13 | $0 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; 40-64 years | 204 | $0 |
2021
| Short return visit (20+ min) | 1,531 | $506 |
| Return visit (30+ min) | 555 | $398 |
| Pure tone audiometry (threshold); air only | 58 | $343 |
| Influenza virus vaccine, trivalent (IIV3), split virus, 0.5 mL dosage, for intramuscular use | 14 | $117 |
| Meningococcal conjugate vaccine, serogroups A, C, W, Y, quadrivalent, diphtheria toxoid carrier (MenACWY-D) or CRM197 carrier (MenACWY-CRM), for intramuscular use | 13 | $95 |
| LIMITED VISUAL FIELD XM UNI/BI I&R | 17 | $43 |
| Short return visit | 1,735 | $40 |
| Most recent systolic blood pressure less than 130 mm Hg (DM) (HTN, CKD, CAD) | 28 | $0 |
| Most recent systolic blood pressure greater than or equal to 140 mm Hg (HTN, CKD, CAD) (DM) | 14 | $0 |
| Most recent diastolic blood pressure less than 80 mm Hg (HTN, CKD, CAD) (DM) | 47 | $0 |
| Most recent diastolic blood pressure 80-89 mm Hg (HTN, CKD, CAD) (DM) | 15 | $0 |
| Urinalysis, by dip stick or tablet reagent for bilirubin, glucose, hemoglobin, ketones, leukocytes, nitrite, pH, protein, specific gravity, urobilinogen, any number of these constituents; automated, without microscopy | 13 | $0 |
2020
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; adolescent (age 12 through 17 years) | 68 | $3,343 |
| Influenza virus vaccine, trivalent (IIV3), split virus, 0.5 mL dosage, for intramuscular use | 77 | $1,647 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 19 | $319 |
| Short return visit (20+ min) | 727 | $127 |
| Developmental screening | 75 | $0 |
| Short return visit | 2,002 | $0 |
| Return visit (30+ min) | 329 | $0 |
| Smoking and tobacco use cessation counseling visit; intermediate, greater than 3 minutes up to 10 minutes | 67 | $0 |
| Alcohol and/or substance (other than tobacco) abuse structured screening (eg, AUDIT, DAST), and brief intervention (SBI) services; 15 to 30 minutes | 62 | $0 |
| Unlisted preventive medicine service | 72 | $0 |
| Screening for depression is documented as being positive and a follow-up plan is documented | 68 | $0 |
| Patient survey results not available | 252 | $0 |
2019
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; adolescent (age 12 through 17 years) | 44 | $1,936 |
| Influenza virus vaccine, trivalent (IIV3), split virus, 0.5 mL dosage, for intramuscular use | 258 | $1,834 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; late childhood (age 5 through 11 years) | 12 | $413 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 71 | $270 |
| Return visit (30+ min) | 1,383 | $101 |
| LIMITED VISUAL FIELD XM UNI/BI I&R | 12 | $30 |
| Urinalysis, by dip stick or tablet reagent for bilirubin, glucose, hemoglobin, ketones, leukocytes, nitrite, pH, protein, specific gravity, urobilinogen, any number of these constituents; automated, with microscopy | 12 | $0 |
| Urinalysis, by dip stick or tablet reagent for bilirubin, glucose, hemoglobin, ketones, leukocytes, nitrite, pH, protein, specific gravity, urobilinogen, any number of these constituents; automated, without microscopy | 13 | $0 |
| Immunization administration through 18 years of age via any route of administration, with counseling by physician or other qualified health care professional; first or only component of each vaccine or toxoid administered | 39 | $0 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 77 | $0 |
| Developmental screening | 205 | $0 |
| Bilateral quantitative screening test of visual acuity | 13 | $0 |
2018
| Developmental screening | 78 | $4,205 |
| Influenza virus vaccine, trivalent (IIV3), split virus, 0.5 mL dosage, for intramuscular use | 236 | $2,476 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; adolescent (age 12 through 17 years) | 39 | $1,799 |
| Pure tone audiometry (threshold); air only | 32 | $392 |
| LIMITED VISUAL FIELD XM UNI/BI I&R | 26 | $66 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 115 | $40 |
| Short return visit (20+ min) | 2,279 | $26 |
| Urinalysis, by dip stick or tablet reagent for bilirubin, glucose, hemoglobin, ketones, leukocytes, nitrite, pH, protein, specific gravity, urobilinogen, any number of these constituents; automated, with microscopy | 28 | $0 |
| Urinalysis, by dip stick or tablet reagent for bilirubin, glucose, hemoglobin, ketones, leukocytes, nitrite, pH, protein, specific gravity, urobilinogen, any number of these constituents; automated, without microscopy | 12 | $0 |
| Short return visit | 217 | $0 |
| Return visit (30+ min) | 835 | $0 |
| Long return visit (40+ min) | 338 | $0 |
Drugs they prescribed that Part D paid
$190,713
Pharmacies billed $190,713 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 2,138) in 2024. At or below the middle of the specialty; the typical family practice clinician is at 2%.
1,787 generic and fewer than 11 brand-name prescriptions · $190,713 in drug cost · 33 antibiotic prescriptions to 30 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Vascepa | 100 | $50,581 | $506 |
| Jardiance | 54 | $40,885 | $757 |
| Farxiga | 17 | $15,665 | $921 |
| Icosapent Ethyl | 41 | $15,572 | $380 |
| Januvia | 19 | $14,271 | $751 |
See all 41 drugs
| Vascepa | 100 | $50,581 | $506 |
| Jardiance | 54 | $40,885 | $757 |
| Farxiga | 17 | $15,665 | $921 |
| Icosapent Ethyl | 41 | $15,572 | $380 |
| Januvia | 19 | $14,271 | $751 |
| Rybelsus | 14 | $13,100 | $936 |
| Atorvastatin | 222 | $2,253 | $10 |
| Albuterol Sulfate Hfa | 50 | $2,089 | $42 |
| Alendronate | 162 | $1,424 | $9 |
| Losartan | 142 | $1,256 | $9 |
| Amlodipine Besylate | 148 | $1,048 | $7 |
| Metoprolol | 60 | $1,037 | $17 |
| Rosuvastatin | 36 | $794 | $22 |
| Fluocinonide | 16 | $706 | $44 |
| Simvastatin | 97 | $698 | $7 |
| Ventolin Hfa | 12 | $670 | $56 |
| Lisinopril | 91 | $583 | $6 |
| Hydrochlorothiazide | 66 | $440 | $7 |
| Metformin | 79 | $399 | $5 |
| Ibandronate | 16 | $358 | $22 |
| Azelastine | 26 | $325 | $13 |
| Levothyroxine | 36 | $320 | $9 |
| Naproxen | 41 | $267 | $7 |
| Montelukast | 24 | $257 | $11 |
| Fosinopril | 14 | $235 | $17 |
| Triamcinolone Acetonide | 21 | $213 | $10 |
| Metoprolol | 16 | $212 | $13 |
| Glimepiride | 18 | $198 | $11 |
| Omeprazole | 29 | $189 | $7 |
| Fluticasone Propionate | 24 | $182 | $8 |
| Gabapentin | 24 | $170 | $7 |
| Hydralazine | 13 | $152 | $12 |
| Azithromycin | 28 | $133 | $5 |
| Allopurinol | 14 | $126 | $9 |
| Loperamide | 18 | $118 | $7 |
| Meclizine | 24 | $118 | $5 |
| Benzonatate | 13 | $80 | $6 |
| Glipizide | 15 | $73 | $5 |
| Famotidine | 12 | $69 | $6 |
| Sertraline | 11 | $44 | $4 |
| Paxlovid | 14 | $0 | $0 |
Year by year
| 2024 | 2,138 | 261 | 0% (0) | None | $190,713 |
| 2023 | 1,891 | 272 | 0% (0) | None | $239,552 |
| 2022 | 2,202 | 303 | 0% (0) | 16% | $268,240 |
| 2021 | 1,873 | 247 | 0% (0) | None | $177,308 |
| 2020 | 1,641 | 265 | 0% (0) | 17% | $145,083 |
| 2019 | 1,706 | 289 | None | 24% | $123,058 |
| 2018 | 1,647 | 259 | 0% (0) | None | $101,919 |
| 2017 | 1,869 | 244 | None | None | $91,985 |
| 2016 | 1,700 | 209 | None | None | $116,053 |
| 2015 | 1,647 | 182 | None | 24% | $105,085 |
| 2014 | 2,034 | 190 | None | None | $137,393 |
| 2013 | 3,019 | 202 | 1% (17) | None | $184,914 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 39 drugs
| Vascepa | 78 | $53,729 | $689 |
| Jardiance | 39 | $40,864 | $1,048 |
| Rybelsus | 21 | $33,666 | $1,603 |
| Farxiga | 11 | $10,883 | $989 |
| Januvia | 11 | $9,498 | $863 |
| Icosapent Ethyl | 18 | $8,780 | $488 |
| Atorvastatin | 211 | $6,297 | $30 |
| Advair Diskus | 14 | $6,030 | $431 |
| Shingrix | 22 | $4,431 | $201 |
| Alendronate | 163 | $3,783 | $23 |
| Losartan | 116 | $3,427 | $30 |
| Amlodipine Besylate | 149 | $3,209 | $22 |
| Lisinopril | 79 | $1,860 | $24 |
| Simvastatin | 75 | $1,821 | $24 |
| Metoprolol | 51 | $1,791 | $35 |
| Albuterol Sulfate Hfa | 36 | $1,514 | $42 |
| Metformin | 76 | $1,499 | $20 |
| Ventolin Hfa | 22 | $1,413 | $64 |
| Rosuvastatin | 31 | $1,208 | $39 |
| Hydrochlorothiazide | 60 | $985 | $16 |
| Azelastine | 29 | $931 | $32 |
| Boostrix Tdap | 14 | $883 | $63 |
| Omeprazole | 34 | $661 | $19 |
| Gabapentin | 17 | $595 | $35 |
| Fluticasone Propionate | 27 | $565 | $21 |
| Fosinopril | 17 | $525 | $31 |
| Montelukast | 15 | $502 | $33 |
| Levothyroxine | 29 | $482 | $17 |
| Benazepril | 14 | $480 | $34 |
| Famotidine | 24 | $479 | $20 |
| Naproxen | 27 | $398 | $15 |
| Allopurinol | 15 | $357 | $24 |
| Glipizide | 16 | $303 | $19 |
| Loperamide | 24 | $246 | $10 |
| Metoprolol | 11 | $213 | $19 |
| Triamcinolone Acetonide | 17 | $185 | $11 |
| Benzonatate | 13 | $106 | $8 |
| Azithromycin | 13 | $100 | $8 |
| Meclizine | 13 | $93 | $7 |
2022: 40 drugs
| Vascepa | 89 | $62,481 | $702 |
| Rybelsus | 41 | $55,392 | $1,351 |
| Jardiance | 42 | $41,188 | $981 |
| Januvia | 11 | $12,718 | $1,156 |
| Advair Diskus | 12 | $5,297 | $441 |
| Ibandronate | 21 | $3,623 | $173 |
| Atorvastatin | 222 | $3,586 | $16 |
| Shingrix | 16 | $3,038 | $190 |
| Alendronate | 193 | $2,945 | $15 |
| Rosuvastatin | 37 | $2,833 | $77 |
| Losartan | 124 | $2,227 | $18 |
| Amlodipine Besylate | 176 | $2,208 | $13 |
| Montelukast | 37 | $2,078 | $56 |
| Azelastine | 28 | $2,018 | $72 |
| Metoprolol | 64 | $1,839 | $29 |
| Albuterol Sulfate Hfa | 29 | $1,571 | $54 |
| Boostrix Tdap | 25 | $1,541 | $62 |
| Simvastatin | 111 | $1,354 | $12 |
| Lisinopril | 101 | $1,148 | $11 |
| Fluocinonide | 17 | $1,101 | $65 |
| Omeprazole | 42 | $927 | $22 |
| Metformin | 97 | $898 | $9 |
| Levothyroxine | 36 | $829 | $23 |
| Hydrochlorothiazide | 59 | $570 | $10 |
| Fosinopril | 24 | $539 | $22 |
| Triamcinolone Acetonide | 20 | $488 | $24 |
| Naproxen | 34 | $448 | $13 |
| Gabapentin | 22 | $421 | $19 |
| Allopurinol | 21 | $329 | $16 |
| Famotidine | 21 | $291 | $14 |
| Fluticasone Propionate | 26 | $288 | $11 |
| Hydralazine | 11 | $267 | $24 |
| Glimepiride | 13 | $253 | $19 |
| Loperamide | 18 | $229 | $13 |
| Glipizide | 17 | $225 | $13 |
| Clopidogrel | 11 | $206 | $19 |
| Benzonatate | 24 | $191 | $8 |
| Benazepril | 12 | $158 | $13 |
| Meclizine | 18 | $142 | $8 |
| Paxlovid (Eua) | 13 | $75 | $6 |
2021: 36 drugs
| Vascepa | 52 | $31,983 | $615 |
| Jardiance | 19 | $24,206 | $1,274 |
| Januvia | 12 | $12,955 | $1,080 |
| Shingrix | 25 | $4,548 | $182 |
| Symbicort | 11 | $3,917 | $356 |
| Rosuvastatin | 47 | $3,405 | $72 |
| Atorvastatin | 157 | $2,352 | $15 |
| Metoprolol | 71 | $2,043 | $29 |
| Alendronate | 161 | $2,004 | $12 |
| Ibandronate | 23 | $1,761 | $77 |
| Losartan | 105 | $1,657 | $16 |
| Amlodipine Besylate | 162 | $1,407 | $9 |
| Simvastatin | 116 | $1,369 | $12 |
| Albuterol Sulfate Hfa | 27 | $1,329 | $49 |
| Fluocinonide | 18 | $1,115 | $62 |
| Lisinopril | 109 | $1,069 | $10 |
| Azelastine | 14 | $811 | $58 |
| Montelukast | 29 | $674 | $23 |
| Metformin | 70 | $595 | $8 |
| Levothyroxine | 19 | $509 | $27 |
| Omeprazole | 37 | $426 | $12 |
| Hydrochlorothiazide | 45 | $379 | $8 |
| Fosinopril | 19 | $355 | $19 |
| Fluticasone Propionate | 32 | $353 | $11 |
| Allopurinol | 19 | $335 | $18 |
| Gabapentin | 15 | $324 | $22 |
| Triamcinolone Acetonide | 13 | $257 | $20 |
| Glimepiride | 18 | $238 | $13 |
| Carvedilol | 11 | $218 | $20 |
| Lovastatin | 15 | $216 | $14 |
| Glipizide | 19 | $203 | $11 |
| Famotidine | 16 | $193 | $12 |
| Naproxen | 27 | $158 | $6 |
| Benazepril | 12 | $132 | $11 |
| Loperamide | 11 | $86 | $8 |
| Meclizine | 14 | $75 | $5 |
2020: 37 drugs
| Vascepa | 44 | $26,864 | $611 |
| Jardiance | 18 | $17,464 | $970 |
| Januvia | 15 | $10,766 | $718 |
| Symbicort | 21 | $7,510 | $358 |
| Advair Diskus | 13 | $5,274 | $406 |
| Shingrix | 29 | $5,037 | $174 |
| Alcohol Pads | 45 | $4,684 | $104 |
| Ventolin Hfa | 34 | $2,038 | $60 |
| Rosuvastatin | 25 | $1,930 | $77 |
| Metoprolol | 61 | $1,705 | $28 |
| Albuterol Sulfate Hfa | 36 | $1,563 | $43 |
| Atorvastatin | 107 | $1,329 | $12 |
| Alendronate | 118 | $1,145 | $10 |
| Losartan | 93 | $1,016 | $11 |
| Simvastatin | 100 | $751 | $8 |
| Olopatadine | 14 | $641 | $46 |
| Amlodipine Besylate | 116 | $626 | $5 |
| Lisinopril | 81 | $543 | $7 |
| Diclofenac | 26 | $542 | $21 |
| Montelukast | 26 | $450 | $17 |
| Fluocinonide | 11 | $447 | $41 |
| Azelastine | 14 | $447 | $32 |
| Metformin | 66 | $427 | $6 |
| Levothyroxine | 13 | $295 | $23 |
| Hydrochlorothiazide | 42 | $264 | $6 |
| Baclofen | 12 | $224 | $19 |
| Lovastatin | 12 | $222 | $18 |
| Fluticasone Propionate | 19 | $179 | $9 |
| Allopurinol | 13 | $169 | $13 |
| Omeprazole | 25 | $157 | $6 |
| Glipizide | 18 | $152 | $8 |
| Naproxen | 21 | $134 | $6 |
| Gabapentin | 16 | $110 | $7 |
| Meclizine | 11 | $105 | $10 |
| Glimepiride | 12 | $96 | $8 |
| Triamcinolone Acetonide | 12 | $92 | $8 |
| Loperamide | 13 | $90 | $7 |
2019: 37 drugs
| Shingrix | 155 | $25,394 | $164 |
| Vascepa | 26 | $13,564 | $522 |
| Metoprolol | 73 | $2,655 | $36 |
| Ventolin Hfa | 43 | $2,432 | $57 |
| Flovent Hfa | 11 | $2,348 | $213 |
| Boostrix Tdap | 40 | $2,335 | $58 |
| Omega-3 Acid Ethyl Esters | 17 | $2,317 | $136 |
| Atorvastatin | 77 | $1,207 | $16 |
| Rosuvastatin | 22 | $1,199 | $55 |
| Alendronate | 109 | $1,158 | $11 |
| Fluocinonide | 19 | $943 | $50 |
| Montelukast | 33 | $813 | $25 |
| Losartan | 80 | $808 | $10 |
| Simvastatin | 104 | $744 | $7 |
| Albuterol Sulfate Hfa | 16 | $724 | $45 |
| Alcohol Pads | 12 | $658 | $55 |
| Amlodipine Besylate | 101 | $635 | $6 |
| Azelastine | 17 | $601 | $35 |
| Lisinopril | 75 | $423 | $6 |
| Metformin | 65 | $423 | $7 |
| Levothyroxine | 15 | $351 | $23 |
| Triamcinolone Acetonide | 15 | $315 | $21 |
| Fluticasone Propionate | 23 | $265 | $12 |
| Fosinopril | 16 | $240 | $15 |
| Donepezil | 13 | $239 | $18 |
| Ranitidine | 30 | $221 | $7 |
| Hydrochlorothiazide | 33 | $220 | $7 |
| Pravastatin | 11 | $216 | $20 |
| Lovastatin | 13 | $161 | $12 |
| Naproxen | 24 | $156 | $6 |
| Allopurinol | 11 | $144 | $13 |
| Baclofen | 11 | $120 | $11 |
| Glipizide | 12 | $120 | $10 |
| Omeprazole | 15 | $98 | $7 |
| Azithromycin | 13 | $89 | $7 |
| Meclizine | 13 | $89 | $7 |
| Ibuprofen | 12 | $61 | $5 |
2018: 34 drugs
| Prolia | 11 | $13,196 | $1,200 |
| Shingrix | 52 | $8,410 | $162 |
| Vascepa | 23 | $7,703 | $335 |
| Symbicort | 20 | $6,015 | $301 |
| Omega-3 Acid Ethyl Esters | 24 | $3,655 | $152 |
| Ventolin Hfa | 51 | $2,869 | $56 |
| Metoprolol | 59 | $2,033 | $34 |
| Boostrix Tdap | 30 | $1,720 | $57 |
| Fluocinonide | 27 | $1,430 | $53 |
| Atorvastatin | 96 | $1,249 | $13 |
| Azelastine | 21 | $1,228 | $58 |
| Rosuvastatin | 19 | $984 | $52 |
| Alendronate | 109 | $907 | $8 |
| Losartan | 83 | $725 | $9 |
| Amlodipine Besylate | 93 | $634 | $7 |
| Simvastatin | 99 | $580 | $6 |
| Montelukast | 31 | $524 | $17 |
| Metformin | 73 | $484 | $7 |
| Lisinopril | 65 | $458 | $7 |
| Naproxen | 42 | $333 | $8 |
| Levothyroxine | 11 | $313 | $28 |
| Omeprazole | 24 | $311 | $13 |
| Triamcinolone Acetonide | 17 | $238 | $14 |
| Hydrochlorothiazide | 30 | $187 | $6 |
| Azithromycin | 26 | $169 | $6 |
| Gabapentin | 17 | $160 | $9 |
| Glipizide | 19 | $144 | $8 |
| Clopidogrel | 11 | $134 | $12 |
| Ranitidine | 22 | $130 | $6 |
| Fluticasone Propionate | 11 | $127 | $12 |
| Metoprolol | 15 | $119 | $8 |
| Meclizine | 18 | $115 | $6 |
| Benazepril | 13 | $111 | $9 |
| Loperamide | 12 | $109 | $9 |
2017: 43 drugs
| Zostavax | 23 | $5,440 | $237 |
| Omega-3 Acid Ethyl Esters | 23 | $5,164 | $225 |
| Vascepa | 16 | $3,023 | $189 |
| Ventolin Hfa | 50 | $2,657 | $53 |
| Boostrix Tdap | 43 | $2,567 | $60 |
| Fluocinonide | 38 | $2,530 | $67 |
| Qvar | 12 | $2,343 | $195 |
| Rosuvastatin | 26 | $2,180 | $84 |
| Atorvastatin | 90 | $1,383 | $15 |
| Azelastine | 34 | $1,270 | $37 |
| Alendronate | 135 | $1,137 | $8 |
| Proair Hfa | 20 | $1,121 | $56 |
| Montelukast | 44 | $782 | $18 |
| Amlodipine Besylate | 118 | $778 | $7 |
| Valsartan | 17 | $723 | $43 |
| Metoprolol | 19 | $700 | $37 |
| Metformin | 78 | $627 | $8 |
| Simvastatin | 100 | $614 | $6 |
| Losartan | 57 | $550 | $10 |
| Naproxen | 73 | $545 | $7 |
| Ibandronate | 11 | $536 | $49 |
| Levothyroxine | 14 | $417 | $30 |
| Lisinopril | 57 | $376 | $7 |
| Lovastatin | 29 | $369 | $13 |
| Atenolol | 49 | $352 | $7 |
| Omeprazole | 33 | $303 | $9 |
| Triamcinolone Acetonide | 20 | $298 | $15 |
| Allopurinol | 12 | $278 | $23 |
| Glipizide | 22 | $230 | $10 |
| Losartan-Hydrochlorothiazide | 14 | $217 | $15 |
| Baclofen | 22 | $213 | $10 |
| Fluticasone Propionate | 15 | $180 | $12 |
| Benazepril | 20 | $174 | $9 |
| Metoprolol | 22 | $171 | $8 |
| Hydrochlorothiazide | 31 | $167 | $5 |
| Carvedilol | 16 | $164 | $10 |
| Gabapentin | 16 | $153 | $10 |
| Azithromycin | 22 | $137 | $6 |
| Donepezil | 12 | $136 | $11 |
| Meclizine | 14 | $100 | $7 |
| Loperamide | 12 | $95 | $8 |
| Ranitidine | 16 | $90 | $6 |
| Ciprofloxacin | 14 | $66 | $5 |
2016: 45 drugs
| Prolia | 22 | $22,092 | $1,004 |
| Januvia | 21 | $12,384 | $590 |
| Crestor | 20 | $8,780 | $439 |
| Zostavax | 33 | $7,148 | $217 |
| Omega-3 Acid Ethyl Esters | 31 | $6,940 | $224 |
| Qvar | 22 | $4,139 | $188 |
| Fluocinonide | 31 | $2,028 | $65 |
| Ibandronate | 13 | $1,988 | $153 |
| Proair Hfa | 34 | $1,825 | $54 |
| Adacel Tdap | 23 | $1,494 | $65 |
| Olopatadine | 12 | $1,340 | $112 |
| Ventolin Hfa | 24 | $1,248 | $52 |
| Alendronate | 127 | $1,119 | $9 |
| Valsartan | 22 | $983 | $45 |
| Boostrix Tdap | 15 | $838 | $56 |
| Atorvastatin | 42 | $702 | $17 |
| Simvastatin | 112 | $690 | $6 |
| Azelastine | 13 | $666 | $51 |
| Acyclovir | 14 | $627 | $45 |
| Losartan | 62 | $561 | $9 |
| Tamsulosin | 11 | $515 | $47 |
| Amlodipine Besylate | 102 | $487 | $5 |
| Montelukast | 29 | $472 | $16 |
| Metformin | 61 | $434 | $7 |
| Naproxen | 60 | $416 | $7 |
| Allopurinol | 20 | $364 | $18 |
| Levothyroxine | 13 | $362 | $28 |
| Atenolol | 43 | $336 | $8 |
| Triamcinolone Acetonide | 22 | $285 | $13 |
| Lovastatin | 24 | $248 | $10 |
| Hydrochlorothiazide | 35 | $223 | $6 |
| Lisinopril | 37 | $212 | $6 |
| Glipizide | 22 | $203 | $9 |
| Losartan-Hydrochlorothiazide | 16 | $170 | $11 |
| Fluticasone Propionate | 18 | $156 | $9 |
| Carvedilol | 18 | $144 | $8 |
| Omeprazole | 20 | $140 | $7 |
| Benazepril | 18 | $129 | $7 |
| Clopidogrel | 12 | $117 | $10 |
| Diphenoxylate-Atropine | 11 | $101 | $9 |
| Glimepiride | 11 | $97 | $9 |
| Azithromycin | 15 | $93 | $6 |
| Ciprofloxacin | 16 | $90 | $6 |
| Meclizine | 11 | $89 | $8 |
| Ranitidine | 15 | $87 | $6 |
2015: 39 drugs
| Crestor | 38 | $17,447 | $459 |
| Prolia | 14 | $13,065 | $933 |
| Januvia | 23 | $11,401 | $496 |
| Omega-3 Acid Ethyl Esters | 34 | $7,211 | $212 |
| Qvar | 28 | $4,918 | $176 |
| Proair Hfa | 64 | $3,282 | $51 |
| Valsartan | 20 | $2,079 | $104 |
| Fluocinonide | 25 | $1,989 | $80 |
| Acarbose | 17 | $1,636 | $96 |
| Alendronate | 132 | $1,132 | $9 |
| Atorvastatin | 50 | $824 | $16 |
| Doxazosin Mesylate | 13 | $734 | $56 |
| Nifedipine Er | 11 | $675 | $61 |
| Simvastatin | 102 | $652 | $6 |
| Amlodipine Besylate | 125 | $607 | $5 |
| Montelukast | 25 | $564 | $23 |
| Losartan | 51 | $517 | $10 |
| Metformin | 72 | $501 | $7 |
| Tamsulosin | 12 | $450 | $37 |
| Levothyroxine | 14 | $367 | $26 |
| Allopurinol | 16 | $343 | $21 |
| Naproxen | 48 | $317 | $7 |
| Triamcinolone Acetonide | 12 | $315 | $26 |
| Atenolol | 49 | $296 | $6 |
| Lovastatin | 21 | $280 | $13 |
| Lisinopril | 49 | $247 | $5 |
| Glipizide | 26 | $192 | $7 |
| Metoprolol | 22 | $150 | $7 |
| Carvedilol | 14 | $149 | $11 |
| Omeprazole | 21 | $147 | $7 |
| Hydrochlorothiazide | 22 | $145 | $7 |
| Losartan-Hydrochlorothiazide | 12 | $141 | $12 |
| Ranitidine | 18 | $115 | $6 |
| Benazepril | 11 | $92 | $8 |
| Naphazoline | 12 | $82 | $7 |
| Azithromycin | 12 | $67 | $6 |
| Ciprofloxacin | 11 | $66 | $6 |
| Amoxicillin | 16 | $61 | $4 |
| Ibuprofen | 12 | $60 | $5 |
2014: 41 drugs
| Prolia | 27 | $23,619 | $875 |
| Crestor | 37 | $18,649 | $504 |
| Diovan | 31 | $8,025 | $259 |
| Januvia | 15 | $7,823 | $522 |
| Lovaza | 40 | $6,644 | $166 |
| Qvar | 29 | $4,924 | $170 |
| Proair Hfa | 88 | $4,343 | $49 |
| Ibandronate | 11 | $2,483 | $226 |
| Zostavax | 13 | $2,344 | $180 |
| Alendronate | 181 | $2,287 | $13 |
| Fluocinonide | 47 | $2,206 | $47 |
| Omega-3 Acid Ethyl Esters | 11 | $1,967 | $179 |
| Acarbose | 14 | $1,421 | $101 |
| Montelukast | 29 | $1,277 | $44 |
| Simvastatin | 141 | $1,066 | $8 |
| Nifedipine Er | 15 | $1,051 | $70 |
| Amlodipine Besylate | 134 | $1,035 | $8 |
| Atorvastatin | 64 | $935 | $15 |
| Losartan | 47 | $799 | $17 |
| Metformin | 77 | $765 | $10 |
| Tamsulosin | 19 | $653 | $34 |
| Clopidogrel | 15 | $614 | $41 |
| Triamcinolone Acetonide | 22 | $531 | $24 |
| Levothyroxine | 29 | $507 | $17 |
| Gemfibrozil | 13 | $417 | $32 |
| Lisinopril | 66 | $392 | $6 |
| Atenolol | 67 | $391 | $6 |
| Naproxen | 50 | $374 | $7 |
| Hydrochlorothiazide | 38 | $290 | $8 |
| Lovastatin | 21 | $290 | $14 |
| Metoprolol | 30 | $200 | $7 |
| Glipizide | 24 | $182 | $8 |
| Allopurinol | 14 | $179 | $13 |
| Carvedilol | 14 | $173 | $12 |
| Ranitidine | 16 | $126 | $8 |
| Omeprazole | 16 | $121 | $8 |
| Azithromycin | 15 | $112 | $7 |
| Baclofen | 13 | $105 | $8 |
| Gabapentin | 17 | $77 | $5 |
| Meloxicam | 13 | $73 | $6 |
| Amoxicillin | 14 | $66 | $5 |
2013: 62 drugs
| Crestor | 56 | $23,269 | $416 |
| Prolia | 19 | $15,999 | $842 |
| Lovaza | 62 | $15,059 | $243 |
| Januvia | 16 | $8,787 | $549 |
| Diovan | 39 | $8,255 | $212 |
| Qvar | 50 | $8,062 | $161 |
| Zostavax | 30 | $5,324 | $177 |
| Ibandronate | 16 | $4,819 | $301 |
| Proair Hfa | 90 | $4,200 | $47 |
| Alendronate | 267 | $4,166 | $16 |
| Patanol | 19 | $3,957 | $208 |
| Valsartan-Hydrochlorothiazide | 15 | $3,465 | $231 |
| Acarbose | 32 | $3,226 | $101 |
| Montelukast | 60 | $2,962 | $49 |
| Actonel | 13 | $2,952 | $227 |
| Clopidogrel | 13 | $2,638 | $203 |
| Pioglitazone | 13 | $2,331 | $179 |
| Simvastatin | 221 | $2,229 | $10 |
| Atorvastatin | 55 | $2,152 | $39 |
| Amlodipine Besylate | 189 | $1,946 | $10 |
| Fluocinonide | 68 | $1,669 | $25 |
| Losartan | 68 | $1,548 | $23 |
| Piroxicam | 14 | $1,186 | $85 |
| Metformin | 83 | $997 | $12 |
| Nifedipine Er | 17 | $954 | $56 |
| Atenolol | 126 | $899 | $7 |
| Gemfibrozil | 26 | $873 | $34 |
| Lovastatin | 47 | $714 | $15 |
| Omeprazole | 46 | $651 | $14 |
| Levothyroxine | 49 | $602 | $12 |
| Lisinopril | 77 | $588 | $8 |
| Losartan-Hydrochlorothiazide | 16 | $583 | $36 |
| Triamcinolone Acetonide | 23 | $493 | $21 |
| Clotrimazole-Betamethasone | 13 | $481 | $37 |
| Naproxen | 63 | $460 | $7 |
| Glyburide | 16 | $424 | $27 |
| Donepezil | 16 | $352 | $22 |
| Lisinopril-Hydrochlorothiazide | 14 | $349 | $25 |
| Azithromycin | 33 | $343 | $10 |
| Metoprolol | 34 | $342 | $10 |
| Ranitidine | 40 | $305 | $8 |
| Doxazosin Mesylate | 14 | $287 | $20 |
| Carvedilol | 14 | $274 | $20 |
| Hydrochlorothiazide | 41 | $266 | $6 |
| Nabumetone | 12 | $252 | $21 |
| Hydroxyzine | 16 | $237 | $15 |
| Glipizide | 24 | $233 | $10 |
| Ciprofloxacin | 36 | $223 | $6 |
| Meclizine | 19 | $195 | $10 |
| Meloxicam | 33 | $191 | $6 |
| Cephalexin | 22 | $181 | $8 |
| Benazepril | 15 | $175 | $12 |
| Proctozone-Hc | 13 | $148 | $11 |
| Amoxicillin | 27 | $143 | $5 |
| Baclofen | 18 | $125 | $7 |
| Ibuprofen | 27 | $122 | $5 |
| Allopurinol | 21 | $118 | $6 |
| Enalapril Maleate | 14 | $114 | $8 |
| Diphenoxylate-Atropine | 22 | $95 | $4 |
| Gabapentin | 12 | $73 | $6 |
| Tramadol | 11 | $65 | $6 |
| Zolpidem | 11 | $36 | $3 |
Money from drug and device companies
$125 in 2025
| 2025 | 1 | 1 | None | $125 |
| 2024 | 4 | 4 | None | $98 |
| 2023 | 7 | 12 | None | $549 |
| 2022 | 6 | 13 | None | $513 |
| 2021 | 4 | 7 | None | $142 |
| 2020 | 4 | 9 | None | $242 |
| 2019 | 4 | 36 | None | $908 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Novo Nordisk | Ozempic | $125 | 1 payment
|
See the published payment
| Novo Nordisk | Meals · 2025-04-23 | Ozempic | $125 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $98
| AstraZeneca Pharmaceuticals LP | Farxiga | $30 | 1 payment
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $24 | 1 payment
|
| Gilead Sciences | None | $22 | 1 payment
|
| GlaxoSmithKline | Arexvy | $21 | 1 payment
|
2023: $549
| Gilead Sciences | Vemlidy | $246 | 3 payments
|
| Inspire Medical Systems | Inspire | $99 | 1 payment
|
| GlaxoSmithKline | Arexvy | $73 | 3 payments
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $46 | 2 payments
|
| Amgen | Repatha | $34 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Farxiga | $25 | 1 payment
|
| Amarin Pharma | Vascepa | $25 | 1 payment
|
2022: $513
| Gilead Sciences | Vemlidy | $279 | 6 payments
|
| Edwards Lifesciences | Edwards Sapien 3 Transcatheter Heart Valve (Thv) | $136 | 2 payments
|
| Amarin Pharma | Vascepa | $48 | 2 payments
|
| AstraZeneca Pharmaceuticals LP | Farxiga | $21 | 1 payment
|
| Sanofi Pasteur | Fluzone Quadrivalent Northern Hemisphere | $15 | 1 payment
|
| Cranial Technologies | Doc Band | $15 | 1 payment
|
2021: $142
| Gilead Sciences | None | $62 | 3 payments
|
| Novo Nordisk | Rybelsus | $33 | 2 payments
|
| Nestle HealthCare Nutrition | Zenpep | $25 | 1 payment
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $22 | 1 payment
|
2020: $242
| Gilead Sciences | Vemlidy | $179 | 6 payments
|
| AbbVie | None | $25 | 1 payment
|
| Amarin Pharma | Vascepa | $23 | 1 payment
|
| Merck Sharp & Dohme | Januvia | $16 | 1 payment
|
2019: $908
| Gilead Sciences | Vemlidy | $468 | 14 payments
|
| Amarin Pharma | Vascepa | $325 | 6 payments
|
| Sunovion Pharmaceuticals | Lonhala Magnair | $84 | 14 payments
|
| AstraZeneca Pharmaceuticals LP | Farxiga | $31 | 2 payments
|
Professional record
- NPI
- 1912013780
- Licence
- CA A42236California A42236: Current · expires 2027-09-30
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- Yes
- Medicaid ID
- CA 00A422360
- Taxonomy
- Family medicine (207Q00000X)
- Mailing address
- 1693 Flanigan Dr, #100, San Jose, CA, 95121
- NPI first listed
- 2006-08-22
- NPI last updated
- 2010-07-13
This is when the NPI record was last certified, not a medical board exam.